Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MPW vs LTC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

LTC Captures Overall Composite Edge (54.1 HOLD vs 52.6 HOLD), While MPW Leads 5–1 on Growth & Valuation Pillars

LTC Overall Winner 6-Pillar Tally: MPW 5 – 1 LTC Matrix Metrics: MPW 3 – 7 LTC

As of Nov 16, 2026, LTC Properties, Inc. (LTC) captures the overall head-to-head institutional edge over Medical Properties Trust, Inc. (MPW) on higher Unified Composite conviction (54.1/100 HOLD vs. 52.6/100 HOLD) after splitting the core matrix 7–3 (led by Growth & Scale), while MPW wins 5–1 across the 6-pillar growth and valuation breakdown. MPW trades at $5.02 (6.7x Forward P/E, 58.2% operating margin) versus LTC at $42.88 (27.3x Forward P/E, 25.6% operating margin).

  • Growth vs. Quality Trade-Off: LTC earns the overall head-to-head edge with a stronger Unified Composite Score (54.1/100 HOLD vs. MPW 52.6/100 HOLD) and -0.17β · 25% Vol risk profile, whereas MPW leads top-line expansion (+9.9% YoY revenue growth, 1.93x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MPW vs LTC
MPW NYSE
Medical Properties Trust, Inc.
Real Estate Investment Trusts
$5.02
-0.59% 1D
Market Cap $3.0B
TTM Revenue $1.01B
Forward P/E 6.7x
Beta / 30D Vol 0.14β · 26% Vol
Unified Composite Score
52.6 / 100 HOLD
Tech 25.0 Fund 45.0 Flow 67.0 Mom 47.3
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.4 · SMA20: $5.18 · SMA50: $5.24
LTC NYSE Head-to-Head Winner
LTC Properties, Inc.
Real Estate Investment Trusts
$42.88
-0.91% 1D
Market Cap $2.5B
TTM Revenue $389M
Forward P/E 27.3x
Beta / 30D Vol -0.17β · 25% Vol
Unified Composite Score
54.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 43
RSI-14: 43.3 · SMA20: $44.09 · SMA50: $43.30

6-Pillar Scorecard Institutional Category Breakdown (MPW 5 – 1 LTC)

Columns: Metric · MPW · LTC
1. Valuation Multiples MPW
Forward P/E 6.7x 27.3x
Trailing P/E 6.7x 4.4x
PEG Ratio 1.93x 5.74x
EV / Revenue 3.0x 6.3x
2. Growth & Scale LTC
Revenue Growth (YoY) +9.9% +69.2%
Earnings Growth (YoY) -48.6% +75.0%
TTM Revenue (USD) $1.01B $389M
Market Cap $3.0B $2.5B
3. Profitability & Quality MPW
Gross Margin 96.4% 56.9%
Operating Margin 58.2% 25.6%
Net Profit Margin -70.1% 129.3%
Return on Equity (ROE) -14.0% 37.0%
4. Balance Sheet & Cash Flow MPW
Cash Generation (TTM) $823M EBITDA $149M EBITDA
Cash Flow Margin 81.6% EBITDA Mgn 38.2% EBITDA Mgn
Net Cash / Leverage $7.75 Book/Sh · -14.0% ROE $29.82 Book/Sh · 37.0% ROE
Dividend Yield 6.34% 5.20%
5. Options & Positioning MPW
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 24.3% (25th %ile) 19.3% (39th %ile)
Put/Call OI Skew 0.79x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat MPW
OpEx & R&D Intensity 38.2% of Rev ($385M) 31.3% of Rev ($122M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MPW (3) vs LTC (7)
Institutional Metric MPW LTC Criterion Row Edge
Market Capitalization
Scale
$3.0B $2.5B Larger Scale MPW
Trailing P/E Ratio
Valuation
6.7x 4.4x Lower Multiple LTC
Forward P/E Ratio
Valuation
6.7x 27.3x Lower Multiple MPW
Revenue Growth (YoY)
Growth
+9.9% +69.2% Higher Growth LTC
Operating Margin (TTM)
Profitability
58.2% 25.6% Higher Margin MPW
Net Profit Margin
Profitability
-70.1% 129.3% Higher Margin LTC
Return on Equity (ROE)
Capital Efficiency
-14.0% 37.0% Higher ROE LTC
52-Week Range Position
Momentum
45% ($4–$6) 70% ($34–$47) Stronger Trend LTC
Beta / 30D Volatility
Risk Regime
0.14β · 26% Vol -0.17β · 25% Vol Lower Realized Risk LTC
Unified Institutional Score
Composite Signal
52.6 / 100 (HOLD) 54.1 / 100 (HOLD) Higher Composite LTC
Trailing 12M Revenue (USD)
Operating Scale
$1.01B $389M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
96.4% 56.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.93x PEG · 3.0x EV/Rev 5.74x PEG · 6.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$823M EBITDA ($7.75 Book/Sh · -14.0% ROE) $149M EBITDA ($29.82 Book/Sh · 37.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon LTC +6.1 pp
MPW: -0.79% · LTC: +5.31%
3M Horizon LTC +1.01 pp
MPW: +0.8% · LTC: +1.81%
6M Horizon LTC +1.01 pp
MPW: +0.8% · LTC: +1.81%
1Y Horizon LTC +1.01 pp
MPW: +0.8% · LTC: +1.81%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPW vs LTC. Trailing 12-month operating profitability (MPW 58.2% vs LTC 25.6%) and valuation multiples (MPW 6.7x vs LTC 27.3x Forward P/E) are benchmarked directly in Pillar 4 below.

MPW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.01B
Gross Margin96.4%
Op. Margin58.2%
ROE / Fwd P/E-14.0% · 6.7x
LTC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$389M
Gross Margin56.9%
Op. Margin25.6%
ROE / Fwd P/E37.0% · 27.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MPW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 24.3%
IV Percentile 25th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MPW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LTC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 19.3%
IV Percentile 39th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LTC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MPW Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $3.0B market capitalization and 58.2% operating margin.
OpEx & R&D Reinvestment 38.2% of Rev ($385M)
90D Engineering Disclosures 0 Published
LTC Moat Profile High-Margin Pricing Power Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $2.5B market capitalization and 25.6% operating margin.
OpEx & R&D Reinvestment 31.3% of Rev ($122M)
90D Engineering Disclosures 0 Published

Investor FAQ MPW vs LTC Key Questions & Quantitative Answers

As of Nov 16, 2026, LTC Properties, Inc. (LTC) captures the overall head-to-head institutional edge over Medical Properties Trust, Inc. (MPW) on higher Unified Composite conviction (54.1/100 HOLD vs. 52.6/100 HOLD) after splitting the core matrix 7–3 (led by Growth & Scale), while MPW wins 5–1 across the 6-pillar growth and valuation breakdown. MPW trades at $5.02 (6.7x Forward P/E, 58.2% operating margin) versus LTC at $42.88 (27.3x Forward P/E, 25.6% operating margin). Growth vs. Quality Trade-Off: LTC earns the overall head-to-head edge with a stronger Unified Composite Score (54.1/100 HOLD vs. MPW 52.6/100 HOLD) and -0.17β · 25% Vol risk profile, whereas MPW leads top-line expansion (+9.9% YoY revenue growth, 1.93x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

LTC leads the Growth & Scale pillar: MPW posts +9.9% YoY revenue growth and -48.6% YoY earnings growth on $1.01B TTM revenue (96.4% gross margin, 58.2% operating margin), compared with LTC at +69.2% YoY revenue growth and +75.0% YoY earnings growth on $389M TTM revenue (56.9% gross margin, 25.6% operating margin). On trailing 12-month operating scale, MPW generates $1.01B in USD-normalized revenue versus $389M for LTC. In operating R&D and SG&A reinvestment, MPW deploys 38.2% of Rev ($385M) (0 90-day corporate R&D disclosures) versus 31.3% of Rev ($122M) (0 disclosures) for LTC.

MPW screens cheaper on headline valuation multiples. MPW trades at 6.7x Forward P/E, 6.7x Trailing P/E, 1.93x PEG, and 3.0x EV/Revenue (81.6% EBITDA margin), whereas LTC trades at 27.3x Forward P/E, 4.4x Trailing P/E, 5.74x PEG, and 6.3x EV/Revenue (38.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MPW (-14.0% ROE) versus LTC (37.0% ROE) capital efficiency.

In options market volatility and institutional positioning, MPW carries 24.3% implied volatility (25th %ile, Balanced (25th–60th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 26% Vol realized risk). By comparison, LTC carries 19.3% implied volatility (39th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.17β · 25% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.